Macrocyclic Compounds (Cyclenium/IRICoR/Universite de Montreal/Institute for Research in Immunology and Cancer)

N/A

Report date: 2025/01/26 15:53:46
NME

Base Information

Drug NameMacrocyclic Compounds (Cyclenium/IRICoR/Universite de Montreal/Institute for Research in Immunology and Cancer)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsImmune System DiseasesNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanada
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesCyclenium Pharma Inc
China Registration ClassN/A

Develop Information

Active CompaniesUniversite De MontrealCyclenium Pharma IncIRICoR +[4] 
Inactive CompaniesN/A
Active IndicationsImmune System DiseasesNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A